Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Phase 0/1 Study of cDNA for TP53, Checkpoint Inhibition and Radiation in Children With Recurrent, Progressive or Refractory CNS Malignancies.
Apply
SGT-53, Radiation, Nivolumab
A Phase 0/1 Study of cDNA for TP53, Checkpoint Inhibition and Radiation in Children With Recurrent, Progressive or Refractory CNS Malignancies.
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step